BSE infection in bovine PrP transgenic mice leads to hyperphosphorylation of tau-protein

Veterinary Microbiology

Volumn 115, Issue 4, 2006, Pages 293-301

  Bautista, M J ^a   Gutierrez J ^a   Salguero, F J ^a   Fernandez de Marco M M ^a   Romero Trevejo, J L ^a   Gomez Villamandos J C ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

BSE; Prion; Tau protein; Tauopathies

Indexed keywords

BIOLOGICAL MARKER; PRION PROTEIN; TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GLIA CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANIMALS; BRAIN; CATTLE; ENCEPHALOPATHY, BOVINE SPONGIFORM; FEMALE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHORYLATION; PRIONS; TAU PROTEINS;

BOS TAURUS; MUS MUSCULUS;

EID: 33746893501     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2006.02.017     Document Type: Article

References (36)

1. Al-Bassam J., Ozer R.S., Safer D., Halpain S., and Milligan R.A. MAP2 and tau bind longitudinally along the outer ridges of microtubule protofilaments. J. Cell. Biol. 157 (2002) 1187-1196
2. Ávila J., Domínguez J., and Díaz-Nido J. Regulation of microtubule dynamics by microtubule-associated protein expression and phosphorylation during neuronal development. Int. J. Dev. Biol. 38 (1994) 13-25
3. Bons N., Mestre-Frances N., Belli P., Cathala F., Gajdusek D.C., and Brown P. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4046-4051
4. Brandner S., Isemann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., and Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 (1996) 339-343
5. Brown D.R. Microglia and prion disease. Microsc. Res. Tech. 54 (2001) 71-80
6. Brown D.R., Herms J., and Kretzschmar H.A. Mouse cortical cells lacking PrP survive in culture with a neurotoxic PrP fragment. Neuroreport 5 (1994) 2057-2060
7. Castilla J., Gutiérrez-Adán A., Brun A., Pintado B., Ramírez M.A., Parra B., Doyle D., Rogers M., Salguero F.J., Sánchez C., Sánchez-Vizcaíno J.M., and Torres J.M. Early detection of PrPres in BSE-infected bovine PrP transgenic mice. Arch. Virol. 148 (2003) 677-691
8. DeArmond S.J., Qui Y., Sánchez H., Spilman P.R., Ninchak-Casey A., Alonso D., and Daggett V. PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strain. J. Neuropathol. Exp. Neurol. 58 9 (1999) 1000-1009
9. Díaz-Nido J., Wandosell F., and Ávila J. Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 23 (2002) 1323-1332
10. Fournier J.G., Escaig-Haye F., and Grigoriev V. Ultrastructural localization of prion protein. Physiological and pathological implications. Microsc. Res. Tech. 50 (2000) 76-88
11. Fournier J.G., Kopp N., Streichenberger N., Escaig-Haye F., Langeveld J., and Brown P. Electron microscopy of brain amyloid plaques from a patient with new variant Creutzfeldt-Jakob diseases. Acta Neuropathol. 99 (2000) 637-642
12. Friedhoff P., von Berger M., Mandelkow E.M., and Mandelkow E. Structure of tau protein and assembly into paired helical filaments. Biochem. Biophys. Acta 1502 (2000) 122-132
13. Giese A., and Kretzschmar H.A. Prion-induced neuronal damage. The mechanism of neuronal destruction in the subacute spongiform encephalopathies. Curr. Top. Microbiol. Immunol. 253 (2001) 203-217
14. Goedert M., Spillantini M.G., Jakes R., Crowther R.A., Vanmechelen E., Probst A., Gotz J., Burki K., and Cohen P. Molecular dissection of paired helical filament. Neurobiol. Aging 16 (1995) 325-334
15. Götz J., Tolnay M., Barmettler R., Chen F., Probst A., and Nitsch R.M. Oligodendroglial tau filament formation in transgenic mice expressing G272V tau. Eur. J. Neurosci. 13 (2001) 2131-2140
16. Hutton M., Lewis J., Dickson D., Yen S.H., and McGowan E. Analysis of taupathies with transgenic mice. Trends Mol. Med. 10 (2001) 467-470
17. Ishizawa K., Komori T., Shimazu T., Yamamoto T., Kitamoto T., Shimazu K., and Hirose T. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Acta Neuropathol. 104 (2002) 342-350
18. Jeffrey M., Fraser J.M., Halliday W.G., Fowler N., Goodsir C.M., and Brown D.A. Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol. Appl. Neurobiol. 21 (1995) 41-49
19. Jeffrey M., Goodbrand I.A., and Goodsir C.M. Pathology of the transmissible spongiform encephalopathies with special emphasis on ultrastructures. Micron 26 (1995) 277-298
20. 2+. Neuron 10 (1993) 797-804
21. Kapaki E., Kilidireas K., Paraskewas G.P., Michalipoulou M., and Patsouris E. Highly increased CSF tau protein and decreased β-amyloid, 1-42 in sporadic CJD, discrimination from Alzheimer's disease?. J. Neurol. Neurosurg. Psychiatry 1 (2001) 401-403
22. Ksiezak-Reding H., and Yen S.H. Structural stability of paired helical filaments requires microtubule binding dominions of tau, a model for self-association. Neuron 6 (1991) 717-728
23. Künzi V., Glatzel M., Nakano M.Y., Greger U.F., van Leuven F., and Aguzzi A. Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau. J. Neurosci. 22 17 (2002) 7471-7477
24. Kurt M.A., Davies D.C., and Kidd M. Paired helical filament morphology varies with intracellular location in Alzheimer's disease brain. Neurosci. Lett. 239 (1997) 41-44
25. Lewis J., McGowan E., Rockwood J., Melrose H., Nacharaju P., van Slegtenhorst M., Gwinn-Hardy K., Murphy M., Baker M., Yu X., Yen S.H., Dickson D.W., Davis P., and Hutton M. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25 (2000) 402-405
26. Lin W.J., Lewis J., Yen S.H., Hutton M., and Dickson D.W. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau. J. Neurocytol. 32 (2003) 1091-1105
27. Pérez M., Rojo A.I., Wandosell F., Díaz-Nido J., and Ávila J. Prion peptide indices neuronal cell death through a pathway involving glycogen synthase kinase 3. Biochem. J. 372 (2003) 129-136
28. Pickering-Brown S. The tau locus and frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 17 (2004) 258-260
29. Raeber A.J., Race R.E., Bradner S., Priola S.A., Sailer A., Bessen R.A., Mucke L., Manson J., Aguzzi A., Oldstone M.B., Weissmann C., and Chesebro B. Astrocyte-specific expression of hamster prion protein, PrP. renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16 (1997) 6057-6065
30. Riemenschneider M., Wagenpfeil S., Vanderstichele H., Otto M., Wiltfang J., Kretzschmar H., Vanmechelen E., Fostl H., and Kurz A. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol. Psychiatry 8 (2003) 343-347
31. Sánchez-Valle R., Pastor P., Yagüe J., Ribalta T., Graus F., Tolosa E., and Saiz A. Analysis of the exon 1 polymorphism in the Tau gene in transmissible spongiform encephalopathies. J. Neurol. 249 (2002) 938-939
32. Scott M., Groth D., Foster D., Torchia M., Yang S.L., DeArmond S.J., and Prusiner S.B. Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73 (1993) 979-988
33. Takuma H., Arawaka S., and Mori H. Isoforms changes of tau protein during development in various species. Dev. Brain Res. 142 (2003) 121-127
34. Talzelt J., Prusiner S.B., and Welch J. Chemical chaperones interfere with the formation of the scrapie prion protein. EMBO J. 15 (1996) 6363-6373
35. Tanemura K., Akagi T., Murayama M., Kikuchi N., Muramaya O., Hashikawa T., Yoshiike Y., Park J.M., Matsuda K., Nakao S., Sun X., Sato S., Yamaguchi H., and Takashima A. Formation of filamentous tau aggregations in transgenic mice expressing V337M human tau. Neurobiol. Dis. 8 (2001) 1036-1045
36. Zheng-Fischhöfer Q., Biernat J., Mandelkow E.M., Illenberg S., and Godeman R. Sequential phosphorylation of tau by glycogen synthase kinase-3 beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur. J. Biochem. 252 (1998) 542-552